SOPH Insider Trading
SOPHiA GENETICS SA | Services-Computer Processing & Data Preparation
Comprehensive Trading Performance Summary
The investment history of corporate insiders at SOPHiA GENETICS SA provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Services-Computer Processing & Data Preparation sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-07 20:03 | 2026-10-05 | Muken Ross | Director, Officer - Chief Executive Officer | SELL | $8.13 | 9,838 | $79,971 | 660,391 | -1.5% |
| 2026-10-07 20:04 | 2026-10-05 | Xu Zhenyu | Officer - Chief Scientific Officer | SELL | $8.12 | 7,394 | $60,075 | 545,493 | -1.3% |
| 2026-10-07 20:04 | 2026-10-05 | Camblong Jurgi | Director, Officer - Executive Chairman | SELL | $8.13 | 40,172 | $326,526 | 3,395,650 | -1.2% |
| 2026-10-07 20:04 | 2026-10-05 | Menu Philippe | Officer - Chief Medical Officer | SELL | $8.13 | 7,394 | $60,100 | 200,993 | -3.5% |
| 2026-10-07 20:04 | 2026-10-05 | CARDOZA GEORGE | Officer - Chief Financial Officer | SELL | $8.10 | 1,592 | $12,897 | 306,726 | -0.5% |
| 2026-10-07 20:04 | 2026-10-05 | Puylaert Kevin | Officer - Chief Sales Officer | SELL | $8.04 | 216 | $1,737 | 147,732 | -0.1% |
| 2026-10-07 20:04 | 2026-10-05 | Verma Abhimanyu | Officer - Chief Technology Officer | SELL | $8.12 | 5,284 | $42,929 | 166,887 | -3.1% |
| 2026-10-07 20:04 | 2026-10-05 | Valente Manuela | Officer - Chief People Officer | SELL | $8.13 | 4,240 | $34,487 | 206,210 | -2.0% |
| 2026-10-07 20:04 | 2026-10-05 | Van Well Daan | Officer - Chief Legal Officer | SELL | $8.12 | 6,168 | $50,100 | 332,716 | -1.8% |
| 2026-09-22 20:02 | 2026-09-21 | Muken Ross | Director, Officer - Chief Executive Officer | SELL | $8.33 | 422 | $3,515 | 670,229 | -0.1% |
| 2026-09-22 20:02 | 2026-09-21 | CARDOZA GEORGE | Officer - Chief Financial Officer | SELL | $8.33 | 774 | $6,447 | 308,318 | -0.3% |
| 2026-09-16 20:01 | 2026-09-14 | Menu Philippe | Officer - Chief Medical Officer | SELL | $7.88 | 5,000 | $39,417 | 208,387 | -2.3% |
| 2026-09-16 20:01 | 2026-09-14 | Xu Zhenyu | Officer - Chief Scientific Officer | SELL | $7.88 | 4,000 | $31,538 | 552,887 | -0.7% |
| 2026-09-14 20:01 | 2026-09-11 | Van Well Daan | Officer - Chief Legal Officer | SELL | $7.63 | 6,168 | $47,089 | 338,884 | -1.8% |
| 2026-09-14 20:01 | 2026-09-10 | Camblong Jurgi | Director, Officer - Executive Chairman | SELL | $7.66 | 8,500 | $65,120 | 3,435,822 | -0.2% |
| 2026-09-10 20:02 | 2026-09-08 | HIBBS KATHY L | Director | SELL | $8.13 | 6,250 | $50,818 | 96,992 | -6.1% |
| 2026-08-31 20:02 | 2026-08-27 | Xu Zhenyu | Officer - Chief Scientific Officer | SELL | $8.91 | 10,000 | $89,096 | 556,887 | -1.8% |
| 2026-08-26 20:04 | 2026-08-25 | Menu Philippe | Officer - Chief Medical Officer | SELL | $8.68 | 5,000 | $43,397 | 213,387 | -2.3% |
| 2026-08-26 20:03 | 2026-08-19 | Verma Abhimanyu | Officer - Chief Technology Officer | SELL | $8.50 | 10,000 | $85,000 | 172,171 | -5.5% |
| 2026-08-26 20:04 | 2026-08-25 | HIBBS KATHY L | Director | SELL | $8.68 | 6,250 | $54,233 | 103,242 | -5.7% |
| 2026-08-21 20:02 | 2026-08-19 | Valente Manuela | Officer - Chief People Officer | OPT+S | $7.94 | 10,000 | $79,439 | 210,450 | 0.0% |
| 2026-08-21 20:01 | 2026-08-19 | Xu Zhenyu | Officer - Chief Scientific Officer | SELL | $8.17 | 20,000 | $163,482 | 566,887 | -3.4% |
| 2026-08-14 20:40 | 2026-08-13 | Xu Zhenyu | Officer - Chief Scientific Officer | SELL | $7.52 | 4,000 | $30,076 | 586,887 | -0.7% |
| 2026-08-14 20:40 | 2026-08-12 | Menu Philippe | Officer - Chief Medical Officer | SELL | $7.52 | 5,000 | $37,580 | 218,387 | -2.2% |
| 2026-08-10 21:14 | 2026-08-07 | Camblong Jurgi | Director, Officer - Executive Chairman | SELL | $7.34 | 28,500 | $209,210 | 3,444,322 | -0.8% |
| 2026-08-10 21:14 | 2026-08-07 | Verma Abhimanyu | Officer - Chief Technology Officer | SELL | $7.60 | 5,000 | $38,000 | 182,171 | -2.7% |
| 2026-08-07 21:35 | 2026-08-05 | Xu Zhenyu | Officer - Chief Scientific Officer | OPT+S | $7.25 | 20,000 | $144,924 | 590,887 | 0.0% |
| 2026-08-05 20:14 | 2026-08-04 | Verma Abhimanyu | Officer - Chief Technology Officer | SELL | $6.95 | 5,000 | $34,772 | 187,171 | -2.6% |
| 2026-08-05 20:14 | 2026-08-04 | Camblong Jurgi | Director, Officer - Executive Chairman | SELL | $6.92 | 20,000 | $138,412 | 3,472,822 | -0.6% |
| 2026-08-05 20:13 | 2026-08-04 | Xu Zhenyu | Officer - Chief Scientific Officer | SELL | $6.92 | 10,000 | $69,168 | 600,887 | -1.6% |
| 2026-07-28 20:03 | 2026-07-27 | Menu Philippe | Officer - Chief Medical Officer | SELL | $5.66 | 5,000 | $28,306 | 223,387 | -2.2% |
| 2026-07-22 20:01 | 2026-07-20 | Camblong Jurgi | Director, Officer - Executive Chairman | OPT+S | $6.45 | 44,381 | $286,098 | 3,492,822 | 0.0% |
| 2026-07-14 20:02 | 2026-07-10 | Camblong Jurgi | Director, Officer - Executive Chairman | SELL | $5.62 | 8,500 | $47,791 | 3,532,622 | -0.2% |
| 2026-07-14 20:02 | 2026-07-13 | Xu Zhenyu | Officer - Chief Scientific Officer | SELL | $5.70 | 4,000 | $22,819 | 610,887 | -0.7% |
| 2026-07-14 20:02 | 2026-07-13 | Menu Philippe | Officer - Chief Medical Officer | SELL | $5.70 | 5,000 | $28,505 | 228,387 | -2.1% |
| 2026-07-08 20:01 | 2026-07-07 | Camblong Jurgi | Director, Officer - Executive Chairman | SELL | $5.28 | 17,685 | $93,327 | 3,541,122 | -0.5% |
| 2026-07-07 20:03 | 2026-07-06 | Camblong Jurgi | Director, Officer - Executive Chairman | SELL | $5.26 | 22,486 | $118,164 | 3,558,807 | -0.6% |
| 2026-07-07 20:03 | 2026-07-06 | Menu Philippe | Officer - Chief Medical Officer | SELL | $5.16 | 7,393 | $38,156 | 233,387 | -3.1% |
| 2026-07-07 20:03 | 2026-07-06 | Puylaert Kevin | Officer - Chief Sales Officer | SELL | $5.03 | 216 | $1,087 | 147,948 | -0.1% |
| 2026-07-07 20:03 | 2026-07-06 | Muken Ross | Director, Officer - Chief Executive Officer | SELL | $5.22 | 9,838 | $51,354 | 670,651 | -1.4% |
| 2026-07-07 20:03 | 2026-07-06 | Xu Zhenyu | Officer - Chief Scientific Officer | SELL | $5.17 | 7,393 | $38,242 | 614,887 | -1.2% |
| 2026-07-07 20:03 | 2026-07-06 | Verma Abhimanyu | Officer - Chief Technology Officer | SELL | $5.10 | 5,285 | $26,957 | 192,171 | -2.7% |
| 2026-07-07 20:03 | 2026-07-06 | Valente Manuela | Officer - Chief People Officer | SELL | $5.05 | 4,241 | $21,430 | 210,450 | -2.0% |
| 2026-07-07 20:04 | 2026-07-06 | CARDOZA GEORGE | Officer - Chief Financial Officer | SELL | $5.29 | 1,592 | $8,419 | 309,092 | -0.5% |
| 2026-07-01 20:03 | 2026-06-29 | Camblong Jurgi | Director, Officer - Executive Chairman | OPT+S | $6.06 | 83,679 | $506,693 | 3,581,293 | 0.0% |
| 2026-06-29 20:07 | 2026-06-25 | Camblong Jurgi | Director, Officer - Chief Executive Officer | OPT+S | $5.80 | 51,442 | $298,153 | 3,601,493 | 0.0% |
| 2026-06-26 20:03 | 2026-06-25 | Menu Philippe | Officer - Chief Medical Officer | SELL | $5.50 | 5,000 | $27,525 | 240,780 | -2.0% |
| 2026-06-26 20:03 | 2026-06-25 | Verma Abhimanyu | Officer - Chief Technology Officer | SELL | $5.51 | 6,944 | $38,229 | 197,456 | -3.4% |
| 2026-06-23 20:01 | 2026-06-22 | Muken Ross | Officer - President | SELL | $5.38 | 422 | $2,270 | 680,489 | -0.1% |
| 2026-06-23 20:01 | 2026-06-22 | CARDOZA GEORGE | Officer - Chief Financial Officer | SELL | $5.38 | 774 | $4,164 | 310,684 | -0.2% |
How to Interpret $SOPH Trades
Not every insider transaction in SOPHiA GENETICS SA is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $SOPH shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for SOPH
Insider activity data for SOPHiA GENETICS SA is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $SOPH, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.